Presidents
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar
Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
scientific board
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland
Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany
John M. Kirkwood
Professor of Clinical and Translational Science, Clinical and Translational Science Institute, University of Pittsburgh, Pennsylvania
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar
Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Ignacio Melero
Professor of Immunology and Consultant, CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain
Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy
Igor Puzanov
Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee
Alessandro Testori
Director of the Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
For information please contact info@melanomabridge.org
